238 related articles for article (PubMed ID: 8539384)
1. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose.
Martin WH; Delbeke D; Patton JA; Sandler MP
Radiology; 1996 Jan; 198(1):225-31. PubMed ID: 8539384
[TBL] [Abstract][Full Text] [Related]
2. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET.
Macfarlane DJ; Cotton L; Ackermann RJ; Minn H; Ficaro EP; Shreve PD; Wahl RL
Radiology; 1995 Feb; 194(2):425-9. PubMed ID: 7824722
[TBL] [Abstract][Full Text] [Related]
3. FDG-SPECT: correlation with FDG-PET.
Martin WH; Delbeke D; Patton JA; Hendrix B; Weinfeld Z; Ohana I; Kessler RM; Sandler MP
J Nucl Med; 1995 Jun; 36(6):988-95. PubMed ID: 7769457
[TBL] [Abstract][Full Text] [Related]
4. Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET.
Chen EQ; MacIntyre WJ; Go RT; Brunken RC; Saha GB; Wong CY; Neumann DR; Cook SA; Khandekar SP
J Nucl Med; 1997 Apr; 38(4):582-6. PubMed ID: 9098206
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
[TBL] [Abstract][Full Text] [Related]
6. Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.
Shulkin BL; Mitchell DS; Ungar DR; Prakash D; Dole MG; Castle VP; Hernandez RJ; Koeppe RA; Hutchinson RJ
Radiology; 1995 Feb; 194(2):495-500. PubMed ID: 7824731
[TBL] [Abstract][Full Text] [Related]
7. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M
J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
[TBL] [Abstract][Full Text] [Related]
8. Technology for FDG SPECT with a relatively inexpensive gamma camera. Work in progress.
Drane WE; Abbott FD; Nicole MW; Mastin ST; Kuperus JH
Radiology; 1994 May; 191(2):461-5. PubMed ID: 8153322
[TBL] [Abstract][Full Text] [Related]
9. Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT.
Mukherji SK; Drane WE; Mancuso AA; Parsons JT; Mendenhall WM; Stringer S
Radiology; 1996 Jun; 199(3):761-6. PubMed ID: 8638002
[TBL] [Abstract][Full Text] [Related]
10. F-18-FDG positron imaging in oncological patients: gamma camera coincidence detection versus dedicated PET.
Zimny M; Kaiser HJ; Cremerius U; Sabri O; Schreckenberger M; Reinartz P; Büll U
Nuklearmedizin; 1999; 38(4):108-14. PubMed ID: 10392375
[TBL] [Abstract][Full Text] [Related]
11. Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas.
Garcia R; Kim EE; Wong FC; Korkmaz M; Wong WH; Yang DJ; Podoloff DA
J Nucl Med; 1996 Sep; 37(9):1476-9. PubMed ID: 8790197
[TBL] [Abstract][Full Text] [Related]
12. 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation.
Stollfuss JC; Glatting G; Friess H; Kocher F; Berger HG; Reske SN
Radiology; 1995 May; 195(2):339-44. PubMed ID: 7724750
[TBL] [Abstract][Full Text] [Related]
13. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose.
Hoh CK; Hawkins RA; Glaspy JA; Dahlbom M; Tse NY; Hoffman EJ; Schiepers C; Choi Y; Rege S; Nitzsche E
J Comput Assist Tomogr; 1993; 17(4):582-9. PubMed ID: 8331230
[TBL] [Abstract][Full Text] [Related]
14. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.
Shreve PD; Steventon RS; Deters EC; Kison PV; Gross MD; Wahl RL
Radiology; 1998 May; 207(2):431-7. PubMed ID: 9577492
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary nodules: differential diagnosis using 18F-fluorodeoxyglucose single-photon emission computed tomography.
Worsley DF; Celler A; Adam MJ; Kwong JS; Müller NL; Coupland DB; Champion P; Finley RJ; Evans KG; Lyster DM
AJR Am J Roentgenol; 1997 Mar; 168(3):771-4. PubMed ID: 9057532
[TBL] [Abstract][Full Text] [Related]
16. Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose.
Steinert HC; Huch Böni RA; Buck A; Böni R; Berthold T; Marincek B; Burg G; von Schulthess GK
Radiology; 1995 Jun; 195(3):705-9. PubMed ID: 7753998
[TBL] [Abstract][Full Text] [Related]
17. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.
Inoue T; Kim EE; Wong FC; Yang DJ; Bassa P; Wong WH; Korkmaz M; Tansey W; Hicks K; Podoloff DA
J Nucl Med; 1996 Sep; 37(9):1472-6. PubMed ID: 8790196
[TBL] [Abstract][Full Text] [Related]
18. Value of fluorine-18-fluorodeoxyglucose and thallium-201 in the detection of pancreatic cancer.
Inokuma T; Tamaki N; Torizuka T; Fujita T; Magata Y; Yonekura Y; Ohshio G; Imamura M; Konishi J
J Nucl Med; 1995 Feb; 36(2):229-35. PubMed ID: 7830119
[TBL] [Abstract][Full Text] [Related]
19. Detection of malignant tumors: whole-body PET with fluorine 18 alpha-methyl tyrosine versus FDG--preliminary study.
Inoue T; Koyama K; Oriuchi N; Alyafei S; Yuan Z; Suzuki H; Takeuchi K; Tomaru Y; Tomiyoshi K; Aoki J; Endo K
Radiology; 2001 Jul; 220(1):54-62. PubMed ID: 11425972
[TBL] [Abstract][Full Text] [Related]
20. Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.
Boland GW; Goldberg MA; Lee MJ; Mayo-Smith WW; Dixon J; McNicholas MM; Mueller PR
Radiology; 1995 Jan; 194(1):131-4. PubMed ID: 7997539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
